Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Prophylaxis was a feature of treatment policy at Newcastle Haemophilia Centre.

  • Read more about Prophylaxis was a feature of treatment policy at Newcastle Haemophilia Centre.

There were 43 patients on home therapy, with a mean Factor 8 usage of 18,796 units per patient per year at Newcastle Haemophilia Centre.

  • Read more about There were 43 patients on home therapy, with a mean Factor 8 usage of 18,796 units per patient per year at Newcastle Haemophilia Centre.

Dr Peter Jones believed the major part of his responsibility was "a regional commitment to the care of children and adults with haemophilia".

  • Read more about Dr Peter Jones believed the major part of his responsibility was "a regional commitment to the care of children and adults with haemophilia".

Dr Peter Jones became director of the Newcastle Haemophilia Centre.

  • Read more about Dr Peter Jones became director of the Newcastle Haemophilia Centre.

The Hepatitis Working Party agreed more information was needed on the risk to patients of developing chronic NANBH, by prospectively following patients first exposed to concentrate or other products, such as people with mild haemophilia undergoing non-emergency surgery.

  • Read more about The Hepatitis Working Party agreed more information was needed on the risk to patients of developing chronic NANBH, by prospectively following patients first exposed to concentrate or other products, such as people with mild haemophilia undergoing non-emergency surgery.

Dr Craske gave a presentation on the work of the Hepatitis Working Party at the UKHCDO annual meeting

  • Read more about Dr Craske gave a presentation on the work of the Hepatitis Working Party at the UKHCDO annual meeting

There was little discussion of issues relating to hepatitis at the haemophilia reference centre directors'

  • Read more about There was little discussion of issues relating to hepatitis at the haemophilia reference centre directors'

The Hepatitis Working Party agreed to continue the study on the Oxford Haemophiliacs to obtain more evidence of the relationship of transaminitis and overt chronic liver disease to mortality.

  • Read more about The Hepatitis Working Party agreed to continue the study on the Oxford Haemophiliacs to obtain more evidence of the relationship of transaminitis and overt chronic liver disease to mortality.

In a meeting of the haemophilia centre directors, it was reported that the 1976 and 1977 annual returns from haemophilia centres demonstrated that an increasingly large amount of commercial Factor 8 concentrate was being used by centres.

  • Read more about In a meeting of the haemophilia centre directors, it was reported that the 1976 and 1977 annual returns from haemophilia centres demonstrated that an increasingly large amount of commercial Factor 8 concentrate was being used by centres.

Dr Mary Collins on behalf of the DHSS said regarding self-sufficiency that there was no limit on the amount of commercial material which Haemophilia Centres could receive.

  • Read more about Dr Mary Collins on behalf of the DHSS said regarding self-sufficiency that there was no limit on the amount of commercial material which Haemophilia Centres could receive.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Current page 87
  • Page 88
  • Page 89
  • Page 90
  • Page 91
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.